ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small”

July 30, 1976

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

March 31, 2000

Hiring Freeze Squeezes NIH, NCI

August 3, 1979